These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20233237)

  • 1. A rare case of an acquired factor VIII inhibitor associated with refractory cytopenia with multilineage dysplasia.
    Azad A; Chionh F; Campbell P
    Intern Med J; 2009 Dec; 39(12):e7-8. PubMed ID: 20233237
    [No Abstract]   [Full Text] [Related]  

  • 2. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndrome and acquired factor VIII inhibitor with severe subcutaneous haemorrhage.
    Lin CK; Liang R; Liu HW; Tse PW; Chan GT
    Acta Haematol; 1991; 85(4):206-8. PubMed ID: 1906670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia.
    Wang H; Wang XQ; Xu XP; Lin GW
    Eur J Haematol; 2009 Dec; 83(6):550-8. PubMed ID: 19737310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monocytosis and myelomonocytic dysplasia in myelodysplastic syndrome].
    Neuwirtová R; Malasková V; Steruská M; Indrák K; Vozobulová V; Haber J; Smolíková A; Musilová J; Jelínek J
    Vnitr Lek; 1990 Aug; 36(8):738-45. PubMed ID: 2136457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
    Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
    Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification.
    Matsuda A; Jinnai I; Iwanaga M; Okamura D; Ishikawa M; Maeda T; Hata T; Kawai N; Miyazaki Y; Bessho M; Tomonaga M
    Am J Clin Pathol; 2013 Aug; 140(2):253-7. PubMed ID: 23897263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired factor VIII inhibitor associated with a prostatic cancer: simultaneous occurrence and healing.
    Lionnet F; Pulik M; Genet P; Lucas G; Sollet JP
    Thromb Haemost; 1995 Feb; 73(2):327-8. PubMed ID: 7792753
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evolution of a refractory cytopenia with multilineage dysplasia and ring sideroblasts to chronic myelomonocytic leukemia].
    Ben Salah N; Gouider E; Belakhal F; El Borgi W; Menif S; Ben Abid H; Jeddi R; Hafsia R
    Tunis Med; 2011 Oct; 89(10):806-7. PubMed ID: 22076892
    [No Abstract]   [Full Text] [Related]  

  • 13. An association of polymyalgia rheumatica with myelodysplastic syndromes.
    Kohli M; Bennett RM
    J Rheumatol; 1994 Jul; 21(7):1357-9. PubMed ID: 7966085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe bleeding in a case of acquired factor VIII inhibitor associated with generalized pustular psoriasis.
    Merlini M; Moccia F; Delucchi M; Grillo G
    Ann Ital Med Int; 2005; 20(4):248-52. PubMed ID: 16610257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
    Rosati S; Anastasi J; Vardiman J
    Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluctuations of haemoglobin values in myelodysplastic syndrome.
    Demiroglu H; Dündar S
    N Z Med J; 1996 Mar; 109(1017):82-3. PubMed ID: 8606829
    [No Abstract]   [Full Text] [Related]  

  • 18. [A 57-year-old patient with peripheral pancytopenia].
    Fink M; Prenninger S; Sauer H
    Internist (Berl); 1989 Mar; 30(3):210-3. PubMed ID: 2654063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Refractory anemia (RA) and refractory cytopenia with multilineage dysplasia (RCMD) in WHO classification: comparison between Japanese and German cases].
    Matsuda A; Germing U
    Rinsho Ketsueki; 2004 Apr; 45(4):268-73. PubMed ID: 15168441
    [No Abstract]   [Full Text] [Related]  

  • 20. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA
    Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.